News Archive
University of Minnesota Professor Awarded R01 Grant from the NCI to Identify Prenatal Origin of Leukemia
MINNEAPOLIS, MN - A study, based at the University of Minnesota, that will examine the prenatal origins of pediatric leukemia, has been awarded a prestigious R01 grant from the National Cancer Institute (NCI).
Dr. Emmanuel Antonarakis named Masonic Cancer Center Associate Director for Translational Research and Director of Genitourinary Oncology in HOT Division
August 31, 2021 - Emmanuel S. Antonarakis, MD, has joined the faculty at the University of Minnesota Medical School where he has been appointed the Associate Director for Translational Research at the Masonic Cancer Center. Dr.
Aaron Schilz, MPA, Named Masonic Cancer Center’s Interim Executive Director
Seanne Falconer, MBA, FACHE Accepts Executive Director Position at the Moores Cancer Center at UC San Diego Health
Aaron Schilz, MPA, Named Masonic Cancer Center’s Interim Executive Director
New Institute Poised to Advance Global Cancer Research and Prevention
The Masonic Cancer Center, School of Public Health, and Medical School provide initial funding for a bold initiative
University of Minnesota team announced as finalists for worldwide Cancer Grand Challenges
MINNEAPOLIS/ST. PAUL (07/13/2021) — A research team led by two world-renowned tobacco researchers from the University of Minnesota has been named as one of 11 global finalists for the Cancer Grand Challenges with the chance to be awarded a…
New UMN Program Putting a Spin on Teaching About Cancer and Cancer Research
A new program led by the Masonic Cancer Center and the University of Minnesota Medical School Program in Health Disparities Research is putting a spin on teaching students about cancer and cancer research.
Masonic Cancer Center Clinical Trials
As one of only 51 NCI-Designated comprehensive cancer centers throughout the United States, the Masonic Cancer Center, University Minnesota’s mission is to serve the people of Minnesota and to put our energy and skills towards ending the…
NCI-designated cancer centers call for urgent action to get cancer-preventing HPV vaccination back on track
The COVID-19 pandemic has interrupted delivery of key health services for children and adolescents, including HPV vaccination for cancer prevention.
Today, doctors and scientists across America at National Cancer Institute (NCI)-…
Clinical Trials Day 2021
Happy Clinical Trials Day! Today is a day to celebrate those who conduct and participate in clinical research. Hear from the MNCCTN HUB, partners, and site staff about why we love working in research and how research creates impact.
Dr. Jeffrey Miller Awarded $9M NIH/NCI P01 Program Project Grant to Develop Off-The-Shelf NK Cells
MINNEAPOLIS/ST. PAUL — Jeffrey Miller, MD, Deputy Director of the Masonic Cancer Center, and his research team have been awarded a $9M National Institutes of Health (NIH) P01 Program Project Grant grant from the National Cancer Institute (…